These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 27778117

  • 21. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC, Incrocci L, Pos FJ, van der Heide UA, Lebesque JV, Aluwini S, Witte MG, Heemsbergen WD.
    Int J Radiat Oncol Biol Phys; 2016 Jun 01; 95(2):680-9. PubMed ID: 27055398
    [Abstract] [Full Text] [Related]

  • 22. Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Sasaki N, Yamazaki H, Shimizu D, Suzuki G, Masui K, Nakamura S, Okabe H, Nishikawa T, Yoshida K.
    Anticancer Res; 2018 Jan 01; 38(1):385-391. PubMed ID: 29277799
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
    Al-Mamgani A, Van Rooij P, Tans L, Teguh DN, Levendag PC.
    Technol Cancer Res Treat; 2013 Apr 01; 12(2):123-30. PubMed ID: 23098281
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results.
    Shen Q, Ma X, Hu W, Chen L, Huang J, Guo Y.
    Radiat Oncol; 2013 Jun 25; 8():152. PubMed ID: 23800149
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H, Feng C, Cai BN, Yang J, Liu HX, Ma L.
    Dis Esophagus; 2017 Feb 01; 30(2):1-8. PubMed ID: 27629865
    [Abstract] [Full Text] [Related]

  • 32. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.
    J Urol; 2001 Sep 01; 166(3):876-81. PubMed ID: 11490237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):685-91. PubMed ID: 18718725
    [Abstract] [Full Text] [Related]

  • 36. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    Cancer; 2009 Dec 01; 115(23):5596-606. PubMed ID: 19670452
    [Abstract] [Full Text] [Related]

  • 37. Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer.
    Dolezel M, Odrazka K, Zouhar M, Vaculikova M, Sefrova J, Jansa J, Paluska P, Kohlova T, Vanasek J, Kovarik J.
    Strahlenther Onkol; 2015 Apr 01; 191(4):338-46. PubMed ID: 25589224
    [Abstract] [Full Text] [Related]

  • 38. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N.
    Cancer; 2015 Apr 01; 121(7):1118-27. PubMed ID: 25423899
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):235-41. PubMed ID: 21163587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.